Successful management of tumor necrosis factor-alpha inhibitor-induced Sweet syndrome in a patient with ulcerative colitis: A case report

2021 ◽  
Author(s):  
Yung-Chun Chang ◽  
Hui-Ju Yang
Keyword(s):  
Ulcerative Colitis ◽  
Case Report ◽  
Tumor Necrosis Factor ◽  
Tumor Necrosis Factor Alpha ◽  
Tumor Necrosis ◽  
Successful Management ◽  
Necrosis Factor Alpha ◽  
Sweet Syndrome ◽  
Factor Alpha ◽  
Necrosis Factor

scholarly journals An unusual presentation of Sweet syndrome in a patient with ulcerative colitis treated with a tumor necrosis factor alpha inhibitor: a case report

2021 ◽  
Author(s):  
Yung-Chun Chang ◽  
Hui-Ju Yang
Keyword(s):  
Ulcerative Colitis ◽  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
Tnf Alpha ◽  
Successful Management ◽  
Necrosis Factor Alpha ◽  
Sweet Syndrome ◽  
Inflammatory Bowel ◽  
Factor Alpha ◽  
Necrosis Factor

Tumor necrosis factor (TNF) alpha inhibitors are widely used to treat inflammatory bowel disease (IBD) and Sweet syndrome is known as an extra-intestinal cutaneous manifestation of IBD. We wish to highlight a paradoxical case and successful management of anti-TNF-agent-induced Sweet syndrome compared with Sweet syndrome treated by anti-TNF agents.

Tumor Necrosis Factor-Alpha Polymorphisms in Ulcerative Colitis-Associated Colorectal Cancer

2008 ◽  
Vol 103 (2) ◽  
pp. 407-415 ◽  
Author(s):  
Megan M. Garrity-Park ◽  
Edward V. Loftus ◽  
Sandra C. Bryant ◽  
William J. Sandborn ◽  
Thomas C. Smyrk
Keyword(s):  
Colorectal Cancer ◽  
Ulcerative Colitis ◽  
Tumor Necrosis Factor ◽  
Tumor Necrosis Factor Alpha ◽  
Tumor Necrosis ◽  
Necrosis Factor Alpha ◽  
Factor Alpha ◽  
Necrosis Factor
Sign in / Sign up

Export Citation Format

Share Document